Surrozen, Inc. (SRZN) — Stock Score Summary

Surrozen, Inc. (SRZN) has a MoatMap StockRank of 41/100 based on Quality (25/100), Value (44/100), and Momentum (59/100) factor scores. The current signal is HOLD. Surrozen is a micro-cap biotechnology company focused on Wnt pathway therapeutics. It is highly speculative, unprofitable, and lacks the established commercial products or manufacturing scale required for our portfolio.

Surrozen, Inc. is a biotechnology company focused on developing regenerative medicines by modulating the Wnt signaling pathway to repair and regenerate damaged tissues and organs. The company's proprietary technologies aim to precisely activate Wnt signaling in a tissue-specific manner, offering a novel approach to treating various diseases with high unmet medical needs, including liver disease and inflammatory bowel disease. Its innovative platform for Wnt pathway modulation provides a strong, specialized competitive moat in the regenerative medicine space.

Key Financial Metrics

Price$21.50
Market Cap$304M
P/E (Forward)-6.12
Price/Book-1.27
Return on Invested Capital-47.4%
Gross Margin0.0%
Operating Margin-209.1%
Revenue Growth408.6%
Free Cash Flow$-26M

Surrozen, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Surrozen, Inc.’s (SRZN) StockRank?
MoatMap’s StockRank for Surrozen, Inc. (SRZN) is 41/100, with a Hold signal. It is a composite of Quality (25), Value (44), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Surrozen, Inc. have an economic moat?
Surrozen, Inc. (SRZN) has a Quality factor score of 25/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Surrozen, Inc. a buy, hold, or sell?
MoatMap’s current signal for Surrozen, Inc. (SRZN) is Hold, based on a StockRank of 41/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Surrozen, Inc. in?
Surrozen, Inc. (SRZN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSRZN deep dive reportAI ChampionsHow we score stocksSense-check another stock